New UCLA-led research questions the assumption that Paxlovid’s effectiveness in reducing COVID-19 hospitalizations and deaths in unvaccinated adults also applies to vaccinated adults.
Six faculty members have been named recipients of the award, which is among the most competitive and prestigious available to early-career researchers.